Search research articles
Contact Us
Filters
Showing results (91-100 of 115) with videos related to
Page
of 12
Sort By:
The Pharmacogenomics Journal
|
July 27, 2011
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials
P P Grimminger, M Shi, C Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Y Shirota, J Stoehlmacher, J Brabender, et al.
Nucleic Acids Research
|
February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)
P V Danenberg, T Horikoshi, M Volkenandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site
H J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, et al.
Cancer Research
|
May 16, 2000
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase
D Banerjee, R Gorlick, A Liefshitz, et al.
Oncogene
|
October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach
K Hayashi, R Metzger, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival
H J Lenz, K Hayashi, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
D Salonga, K D Danenberg, M Johnson, et al.
Investigative Ophthalmology & Visual Science
|
November 1, 1993
Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction
J Kan-Mitchell, P E Liggett, C R Taylor, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 115) with videos related to
Sort By:
Page
of 12
The Pharmacogenomics Journal
|
July 27, 2011
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials
P P Grimminger, M Shi, C Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Y Shirota, J Stoehlmacher, J Brabender, et al.
Nucleic Acids Research
|
February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)
P V Danenberg, T Horikoshi, M Volkenandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site
H J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, et al.
Cancer Research
|
May 16, 2000
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase
D Banerjee, R Gorlick, A Liefshitz, et al.
Oncogene
|
October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach
K Hayashi, R Metzger, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival
H J Lenz, K Hayashi, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
D Salonga, K D Danenberg, M Johnson, et al.
Investigative Ophthalmology & Visual Science
|
November 1, 1993
Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction
J Kan-Mitchell, P E Liggett, C R Taylor, et al.
Page
of 12